As part of the Decentralized Trials and Research Alliance's (DTRA) TGIF-DCT podcast series, mdgroup will join forces with Q2 Solutions to explain how tearing down barriers between the various vendors and service providers involved in such studies is a simple yet effective starting point.
Hosted by DTRA founder Craig Lipset, mdgroup's Director of Decentralized Clinical Solutions, Tom Brazier, will present with Q2 Solutions' Decentralized Trial Solutions Director, John Corcoran, and Manager, Stephanie Larimer.
This event will take place on Dec. 9, 12-1pm, EST. This podcast discussion forms part of a series of Clubhouse events, organized by the DTRA, of which mdgroup is a founding member, aimed at providing all stakeholders with an informal space to share DCT experiences and best practice.
Read more about the event here.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.